IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TABELLINI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.227
AS - Asia 3.260
EU - Europa 3.159
SA - Sud America 570
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 55
OC - Oceania 18
Totale 13.487
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.110
CN - Cina 1.401
PL - Polonia 947
SG - Singapore 894
UA - Ucraina 562
BR - Brasile 484
FR - Francia 411
IT - Italia 347
HK - Hong Kong 284
DE - Germania 259
VN - Vietnam 211
FI - Finlandia 178
GB - Regno Unito 129
IN - India 121
RU - Federazione Russa 105
TR - Turchia 103
IE - Irlanda 90
CA - Canada 78
BD - Bangladesh 73
SE - Svezia 46
AR - Argentina 36
KR - Corea 26
ID - Indonesia 21
IQ - Iraq 19
AU - Australia 18
ZA - Sudafrica 18
MX - Messico 17
NL - Olanda 17
SA - Arabia Saudita 16
JP - Giappone 14
EC - Ecuador 13
AT - Austria 12
BE - Belgio 12
ES - Italia 12
NG - Nigeria 11
CO - Colombia 8
CZ - Repubblica Ceca 8
PK - Pakistan 8
VE - Venezuela 8
EG - Egitto 7
IR - Iran 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
EU - Europa 6
MA - Marocco 6
PE - Perù 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
KZ - Kazakistan 5
LT - Lituania 5
OM - Oman 5
PH - Filippine 5
CH - Svizzera 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
MU - Mauritius 4
MY - Malesia 4
DZ - Algeria 3
GT - Guatemala 3
JO - Giordania 3
LV - Lettonia 3
TN - Tunisia 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
IM - Isola di Man 2
KG - Kirghizistan 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 13.297
Salva come PNG Salva come JPEG
Città #
Warsaw 945
Fairfield 722
Woodbridge 552
Ashburn 525
Singapore 468
Houston 437
Shenzhen 408
Jacksonville 396
Hong Kong 281
Cambridge 275
Seattle 270
Wilmington 267
Ann Arbor 245
San Jose 241
Beijing 234
The Dalles 183
New York 167
Princeton 166
Brescia 156
Chandler 133
Nanjing 118
Helsinki 93
Los Angeles 89
Dublin 87
Dearborn 79
Council Bluffs 75
Lauterbourg 75
Istanbul 71
Nanchang 69
Columbus 66
Ho Chi Minh City 63
Moscow 51
Dallas 49
São Paulo 47
Shenyang 46
Buffalo 41
Milan 40
San Diego 40
Des Moines 38
Hanoi 37
Changsha 36
Munich 36
San Francisco 33
Hebei 32
Santa Clara 32
Jinan 31
Chicago 30
London 28
Tianjin 27
Montreal 26
Phoenix 26
Redondo Beach 26
Dong Ket 24
Jiaxing 22
Shanghai 22
Toronto 22
Orem 21
Ningbo 20
Taizhou 20
Seongnam 19
Denver 16
Jakarta 15
Rio de Janeiro 15
Chennai 14
Kunming 14
Turku 14
Zhengzhou 14
Brasília 13
Indianapolis 13
Kocaeli 13
Tokyo 13
Atlanta 12
Augusta 12
Verona 12
Abuja 11
Brooklyn 11
Charlotte 11
Haiphong 10
Hangzhou 10
Riyadh 10
Brussels 9
Johannesburg 9
Stockholm 9
Amsterdam 8
Baghdad 8
Campinas 8
Da Nang 8
Haikou 8
Lancaster 8
Mexico City 8
Mumbai 8
Nuremberg 8
Boardman 7
Frankfurt am Main 7
Manchester 7
Quito 7
Rome 7
Salvador 7
Sydney 7
Tashkent 7
Totale 9.286
Salva come PNG Salva come JPEG
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 579
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 395
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 388
NFKB1 regulates human NK cell maturation and effector functions 347
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 331
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 302
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 293
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 263
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 234
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 224
CTLA-4 regulates human Natural Killer cell effector functions 212
The RAC2-PI3K axis regulates human NK cell maturation and function 210
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 206
A threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. 205
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 197
Effects of opioid therapy on human natural killer cells. 190
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. 187
Inherited DOCK2 deficiency in patients with early-onset invasive infections 187
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. 170
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 157
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 157
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 156
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 154
Rab3A and Rab3D control the total granule number and the fraction of granules docked at the plasma membrane in PC12 cells 152
Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways 150
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels 150
Re-examination of the mechanisms regulating nuclear inositol lipid metabolism. 149
Flow cytometric detection of total and serine 473 phosphorylated Akt. 148
Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 147
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling 147
Nuclear changes in necrotic HL-60 cells. 143
The emerging multiple roles of nuclear Akt 142
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 142
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 139
Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study 138
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 138
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix. 136
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. 135
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 135
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 134
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 134
Localization of the small monomeric GTPases Rab3D and Rab3A in the AtT-20 rat pituitary cell line. 133
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation 132
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. 131
Nuclear apoptotic changes: an overview 131
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 131
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 131
Nuclear lipids: new functions for old molecules? 130
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 130
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 129
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 127
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy. 125
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. 124
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 122
Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study 122
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway. 122
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 122
Further considerations on the intranuclear distribution of HMGI/Y proteins. 121
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 118
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 116
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 115
P85α is an intrinsic regulator of human natural killer cell effector functions 114
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 111
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 110
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 109
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: Involvement of FOXO3a. 109
The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells. 108
Phosphoinositide-specific phospholipase Cbeta1 expression is not linked to nerve growth factor-induced differentiation, cell survival or cell cycle control in PC12 rat pheocromocytoma cells. 108
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 108
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. 106
The controversial nuclear matrix: a balanced point of view. 105
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1 102
Natural killer cell impairment in ovarian clear cell carcinoma 100
FGF-trapping hampers cancer stem-like cells in uveal melanoma 98
Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by {alpha}-actinin. 97
Nuclear expression of diacylgycerol kinases: possibile involvement in DNA replication 97
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 96
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. 95
Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. 94
Molecular characterization of protein kinase C-alpha binding to lamin A. 94
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. 94
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 93
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 93
Insulin-like growth factor-I-dependent stimulation of nuclear phospholipase C-beta1 activity in Swiss 3T3 cells requires an intact cytoskeleton and is paralleled by increased phosphorylation of the phospholipase. 87
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 87
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 85
Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party 66
The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients. 37
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immunecheckpoint blockade 32
Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas 30
Role of heparin-binding mediators in the resistance to anti-VEGF therapies in diabetic retinopathy 7
Totale 13.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.865
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022766 0 158 21 56 15 32 38 50 34 97 66 199
2022/2023519 125 1 3 31 33 146 5 52 59 1 28 35
2023/20241.004 36 11 462 27 17 130 32 25 163 2 8 91
2024/20251.405 11 3 6 184 155 110 119 48 158 113 332 166
2025/20263.166 269 395 260 515 306 178 411 160 199 258 135 80
2026/2027306 203 103 0 0 0 0 0 0 0 0 0 0
Totale 13.487